Leap Therapeutics, Inc. (CYPH)
CIK 1509745 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Leap Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 14, 2026 | 4 | 0001231919-26-001453 |
| Oct 14, 2026 | 4 | 0002092596-26-000004 |
| Sep 25, 2026 | 4 | 0001104659-26-111063 |
| Sep 25, 2026 | 3 | 0001104659-26-111065 |
| Sep 25, 2026 | 4 | 0001104659-26-111061 |
| Sep 22, 2026 | 8-K | 0001104659-26-109463 |
| Sep 2, 2026 | 8-K | 0001104659-26-104753 |
| Aug 27, 2026 | 4 | 0001104659-26-102467 |
| Aug 26, 2026 | 144 | 0001949846-26-000546 |
| Aug 24, 2026 | 3 | 0001104659-26-100321 |
| Aug 24, 2026 | 4 | 0001104659-26-100330 |
| Aug 19, 2026 | 4 | 0001231919-26-000951 |
| Aug 19, 2026 | SCHEDULE 13D/A | 0002085726-26-000002 |
| Aug 19, 2026 | 4 | 0002092596-26-000002 |
| Aug 18, 2026 | 8-K | 0001104659-26-098120 |
| Aug 12, 2026 | 10-Q | 0001104659-26-094449 |
| Aug 12, 2026 | 8-K | 0001104659-26-094445 |
| Jul 21, 2026 | 8-K | 0001104659-26-085399 |
| Jul 2, 2026 | 4 | 0001104659-26-080494 |
| Jul 2, 2026 | 4 | 0001104659-26-080496 |
| Jul 2, 2026 | 4 | 0001104659-26-080491 |
| Jul 2, 2026 | 4 | 0001104659-26-080495 |
| Jul 2, 2026 | 4 | 0001104659-26-080490 |
| Jul 2, 2026 | 4 | 0001104659-26-080493 |
| Jul 2, 2026 | 4 | 0001104659-26-080492 |